Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Colorcon
McKinsey
Daiichi Sankyo
McKesson
Healthtrust
QuintilesIMS
Baxter
Federal Trade Commission

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020941

« Back to Dashboard

NDA 020941 describes ABREVA, which is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from two suppliers. Additional details are available on the ABREVA profile page.

The generic ingredient in ABREVA is docosanol. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the docosanol profile page.
Summary for 020941
Tradename:ABREVA
Applicant:Glaxosmithkline
Ingredient:docosanol
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020941
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ABREVA docosanol CREAM;TOPICAL 020941 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0200 0135-0200-01 2 g in 1 TUBE (0135-0200-01)
ABREVA docosanol CREAM;TOPICAL 020941 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0200 0135-0200-03 2 g in 1 BOTTLE, PUMP (0135-0200-03)

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CREAM;TOPICALStrength10%
Approval Date:Jul 25, 2000TE:RLD:Yes

Expired US Patents for NDA 020941

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline ABREVA docosanol CREAM;TOPICAL 020941-001 Jul 25, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline ABREVA docosanol CREAM;TOPICAL 020941-001 Jul 25, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Farmers Insurance
Cantor Fitzgerald
QuintilesIMS
Boehringer Ingelheim
Accenture
UBS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.